CAVIN1 and central nervous system cancer: In gliomas, PTRF/Cavin-1 not only serves as a marker for patient prognosis, but also promotes malignant behavior by affecting tumor cell endocytosis and exocytosis, reprogramming tumor lipid metabolism, and remodeling the extracellular matrix of tumors (59).